AI assistant
BIODESIX INC — Director's Dealing 2023
Apr 4, 2023
34472_dirs_2023-04-04_25fbfdd3-e99b-44fe-9d76-4f692085b1aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2023-03-31
Reporting Person: Kayyem Jon Faiz (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | Common Stock | M | 145833 | — | Acquired | 177452 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | Restricted Stock Units | $ | M | 145833 | Disposed | Common Stock (145833) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 173913 | Indirect |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2: These securities are directly owned by The Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem and his spouse serve as co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
F3: These RSUs vested in full on March 31, 2023.
F4: This amount includes 4,878 deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.